Poly Medicure Limited (NSE:POLYMED)
1,651.60
+1.40 (0.08%)
Jun 29, 2026, 10:10 AM IST
Poly Medicure Revenue
In the fiscal year ending March 31, 2026, Poly Medicure had annual revenue of 18.75B INR with 12.30% growth. Poly Medicure had revenue of 5.35B in the quarter ending March 31, 2026, with 21.25% growth.
Revenue
18.75B
Revenue Growth
+12.30%
P/S Ratio
8.92
Revenue / Employee
6.08M
Employees
3,082
Market Cap
167.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.75B | 2.05B | 12.30% |
| Mar 31, 2025 | 16.70B | 2.94B | 21.37% |
| Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
| Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
| Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Alembic Pharmaceuticals | 73.45B |
| Sagility | 71.93B |
| NATCO Pharma | 40.78B |
| Syngene International | 37.39B |
Poly Medicure News
- 4 weeks ago - Poly Medicure cancels investor meeting scheduled for 27th May 2026 - Business Upturn
- 4 weeks ago - Poly Medicure Transcript: Q4 25/26 - Transcripts
- 4 weeks ago - Poly Medicure Quarterly report: Q4 2026 - Filings
- 4 weeks ago - Poly Medicure Slides: Q4 2026 - Filings
- 4 weeks ago - Top losers in morning trade: gujarat state petronet at ₹268.35 down 7.13%, poly medicure at ₹1,520.00 falls 4.89%, polyplex corporation at ₹914.50 down 4.88% - Business Upturn
- 4 weeks ago - Poly Medicure Q4 Results: Net profit falls 27.8% YoY to Rs 66.3 crore, revenue rises 21.3% - Business Upturn
- 4 months ago - Poly Medicure Slides: Investor presentation - Filings
- 5 months ago - Poly Medicure Transcript: Q3 25/26 - Transcripts